跳至主要内容
临床试验/CTRI/2009/091/000762
CTRI/2009/091/000762已完成1 期

A single center, open-label, randomized, two-period, crossover, single-dose study to determine the effect of food on the bioavailability of fixed combination SPA100 (aliskiren/amlodipine 300/10 mg oral tablets) in healthy subjects

ovartis Healthcare Private Limited,Andhra Pradesh, India 500 081.0 个研究点目标入组 36 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
36

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Healthy male and post menopausal female subjects age 18 to 45 years ready for written informed consent

排除标准

  • Heavy smokers, drug addicts and alcoholics

研究者

发起方
ovartis Healthcare Private Limited,Andhra Pradesh, India 500 081.

相似试验